Corrigendum to “Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study” [The Lancet Regional Health – Europe 41 (2024) 100912]

IF 13.6 Q1 HEALTH CARE SCIENCES & SERVICES

Lancet Regional Health-Europe Pub Date : 2024-07-01 DOI:10.1016/j.lanepe.2024.100973

Maria Lucia Iacovino , Simone Celant , Luca Tomassini , Laura Arenare , Andrea Caglio , Andrea Canciello , Flavio Salerno , Pier Paolo Olimpieri , Susanna Di Segni , Antonella Sferrazza , Maria Carmela Piccirillo , Giordano Domenico Beretta , Carmine Pinto , Livio Blasi , Saverio Cinieri , Luigi Cavanna , Massimo Di Maio , Pierluigi Russo , Francesco Perrone

引用次数: 0

查看原文本刊更多论文

意大利肿瘤药物监测登记处和临床试验中患者基线特征的比较：一项真实世界横断面研究"[《柳叶刀》区域健康--欧洲 41 (2024) 100912] 更正

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Regional Health-Europe Multiple-

CiteScore

19.90

自引率

1.40%

发文量

260

审稿时长

9 weeks

期刊介绍： The Lancet Regional Health – Europe, a gold open access journal, is part of The Lancet's global effort to promote healthcare quality and accessibility worldwide. It focuses on advancing clinical practice and health policy in the European region to enhance health outcomes. The journal publishes high-quality original research advocating changes in clinical practice and health policy. It also includes reviews, commentaries, and opinion pieces on regional health topics, such as infection and disease prevention, healthy aging, and reducing health disparities.